Moderna, Eli Lilly and Apple Rise Premarket
Investing.com
Published Dec 15, 2020 08:12AM ET
By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Tuesday, December 15th. Please refresh for updates.
-
Eli Lilly (NYSE:LLY) stock rose 2.1% after the drugmaker said it would buy Prevail Therapeutics (NASDAQ:PRVL), up 86%, in a deal valued at $1.04 billion, to expand its presence in gene therapy. It also raised its quarterly dividend by 15%.
-
Moderna (NASDAQ:MRNA) stock rose 3.2% after the FDA said the biotech’s Covid-19 vaccine meets expectations for emergency use, a crucial step towards the drug being approved.
-
Boeing (NYSE:BA) stock rose 0.8% despite the aircraft manufacturer’s quality inspectors finding production flaws in other parts of its 787 Dreamliner than the areas previously disclosed.
-
Apple (NASDAQ:AAPL) stock rose 2% after Nikkei reported that the company plans to manufacture up to 96 million iPhones in the first half of 2021, a nearly 30% year-on-year increase.
-
Amazon (NASDAQ:AMZN) stock rose 0.7% despite California Attorney General Xavier Becerra petitioning a court to force the e-commerce giant to comply with the state’s investigation into the company’s handling of the coronavirus pandemic.
-
Pinterest (NYSE:PINS) stock rose 0.4% after the social media firm agreed to pay $22.5 to settle claims of gender discrimination brought by its former chief operating officer.
-
Twitter (NYSE:TWTR) stock fell 0.1% after Ireland's data regulator fined the social media giant around $500,000 for a bug that made some private tweets public, in the first sanction against a U.S. firm under a new European Union data privacy system.
- Chewy (NYSE:CHWY) stock rose 0.7% after the WSJ reported that the pet-supply retailer plans to ramp up the number of products it offers to help boost orders.
Get The News You Want
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.